a year ago
DYN
AnalystsDebjit ChattopadhyayDebjit Chattopadhyay's Stock Forecasts
AnalystsDebjit Chattopadhyay
Sectors:
Industries:
Analyst Ranking
Bottom 11%
#4349 out of 4870 analysts
Average Return
-2.81%
Win Rate
43%30 out of 69
Risk vs Reward
Poor
Good
Debjit Chattopadhyay's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Jounce Therapeutics IncJNCE | +158.50% | $4.94 | $12.77 | 2020-03-01 - 2021-03-02 | Buy |
Sarepta Therapeutics IncSRPT | +134.33% | $55.25 | $129.47 | 2017-11-30 - 2018-11-30 | Buy |
Centessa Pharmaceuticals PLCCNTA | +101.08% | $4.64 | $9.33 | 2023-06-11 - 2024-06-11 | Strong Buy |
Krystal Biotech IncKRYS | +99.10% | $81.91 | $163.08 | 2023-02-27 - 2024-02-28 | Strong Buy |
Soleno Therapeutics IncSLNO | +96.31% | $27.93 | $54.83 | 2023-11-20 - 2024-11-20 | Strong Buy |
Debjit Chattopadhyay Analyst Color
Get additional color on Debjit Chattopadhyay's coverage of popular stocks
a year ago
KRYS
Debjit Chattopadhyay's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Ionis Pharmaceuticals IncIONS | 4 | Strong Buy | $64.00 | +101.83% | Maintains | a day ago |
Maze Therapeutics IncMAZE | 2 | Strong Buy | $19.00 | +79.41% | Reiterates | a month ago |
Soleno Therapeutics IncSLNO | 2 | Strong Buy | $81.00 | +7.97% | Maintains | a month ago |
Centessa Pharmaceuticals PLCCNTA | 5 | Strong Buy | $28.00 | +107.41% | Reiterates | a month ago |
Beam Therapeutics IncBEAM | 2 | Strong Buy | $78.00 | +293.34% | Reiterates | 2 months ago |
Prime Medicine IncPRME | 3 | Strong Buy | $18.00 | +934.48% | Reiterates | 5 months ago |
Benitec Biopharma IncBNTC | 2 | Strong Buy | $17.00 | +17.97% | Reiterates | 5 months ago |
Amicus Therapeutics IncFOLD | 2 | Strong Buy | $15.00 | +124.55% | Maintains | 6 months ago |
Rezolute IncRZLT | 1 | Strong Buy | $11.00 | +177.78% | Initiates Coverage On | 8 months ago |
Dyne Therapeutics IncDYN | 3 | Strong Buy | $50.00 | +317.01% | Maintains | 9 months ago |
Vertex Pharmaceuticals IncVRTX | 5 | Strong Buy | $558.00 | +11.86% | Maintains | 9 months ago |
Precision Biosciences IncDTIL | 2 | Strong Buy | $19.00 | N/A | Initiates Coverage On | a year ago |
Voyager Therapeutics IncVYGR | 1 | Strong Buy | $22.00 | N/A | Initiates Coverage On | a year ago |
Krystal Biotech IncKRYS | 3 | Strong Buy | $175.00 | N/A | Maintains | a year ago |
Newamsterdam Pharma Co NvNAMS | 1 | Strong Buy | $30.00 | N/A | Initiates Coverage On | a year ago |
Biomarin Pharmaceutical IncBMRN | 3 | Strong Buy | $110.00 | N/A | Reiterates | 2 years ago |
Uniqure NvQURE | 3 | Strong Buy | $53.00 | N/A | Reiterates | 2 years ago |
Allogene Therapeutics IncALLO | 1 | Buy | $29.00 | N/A | Maintains | 2 years ago |
Passage Bio IncPASG | 2 | Strong Buy | $11.00 | N/A | Maintains | 2 years ago |
Ultragenyx Pharmaceutical IncRARE | 2 | Strong Buy | $50.00 | N/A | Upgrades | 3 years ago |
Alnylam Pharmaceuticals IncALNY | 1 | Hold | N/A | N/A | Downgrades | 3 years ago |
Taysha Gene Therapies IncTSHA | 1 | Strong Buy | $28.00 | N/A | Initiates Coverage On | 3 years ago |
Intellia Therapeutics IncNTLA | 1 | Strong Buy | $170.00 | N/A | Initiates Coverage On | 4 years ago |
Tourmaline Bio IncTRML | 1 | Strong Buy | $26.00 | N/A | Initiates Coverage On | 4 years ago |
Freeline Therapeutics Holdings PLCFRLN | 1 | Strong Buy | $255.00 | N/A | Initiates Coverage On | 4 years ago |
Sarepta Therapeutics IncSRPT | 4 | Buy | $221.00 | N/A | Maintains | 5 years ago |
Galapagos NvGLPG | 3 | Hold | $123.00 | N/A | Downgrades | 5 years ago |
Sierra Oncology IncSRRA | 1 | Buy | $20.00 | N/A | Initiates Coverage On | 5 years ago |
Tectonic Therapeutic IncTECX | 3 | Hold | $156.00 | N/A | Downgrades | 5 years ago |
Zymeworks IncZYME | 1 | Buy | $60.00 | N/A | Reiterates | 5 years ago |
Jounce Therapeutics IncJNCE | 1 | Buy | $10.00 | N/A | Reiterates | 5 years ago |
Wave Life Sciences LtdWVE | 1 | Buy | $20.00 | N/A | Maintains | 5 years ago |
Immunogen IncIMGN | 2 | Hold | $3.50 | N/A | Downgrades | 6 years ago |
Audentes Therapeutics IncBOLD1 | 1 | Buy | $33.00 | N/A | Maintains | 7 years ago |
Global Blood Therapeutics IncGBT | 4 | Buy | $125.00 | N/A | Maintains | 7 years ago |
Agios Pharmaceuticals IncAGIO | 2 | Hold | N/A | N/A | Downgrades | 8 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.